January 24, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for ...

January 24, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused ...

Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...

Historically, the process of applying for a Chinese visa involved manual documentation, in-person visits, and extended waiting times. With ServiceIn's advanced platform, these challenges have been ...

The United States said on Friday that extending the ceasefire in Lebanon is critically important and expressed satisfaction ...